Company Profile

EPS Holdings, Inc., formerly EPS Corporation, mainly offers medical-related services. Contract Research Organization (CRO) segment provides clinical trials operating and management-related services. Site Management Organization (SMO) segment offers clinical research coordinators (CRCs) to medical institutions. Contract Research Organization (CSO) segment provides drug information and awareness advertisement reception service to medical and pharmaceutical, healthcare industries. Pharmaceutical and Medical Information Technology-related segment is engaged in the development and support service of systems used for clinical trials.

Employees

6,716

Sector

Biotechnology & Medical Research

More about the company

09-09	Wisdoms Group International Co., Limited entered into an agreement to acquire 24.8% stake in EPS Creative Health Technology Group Limited from EPS Holdings, Inc. for HKD 82 million.	CI
25-09-11	Shanghai EPS and Beijing Global and Ep-Bio Enter into the CRO Services Framework Agreement	CI
24-10-01	EPS Holdings, Inc. agreed to acquire EPS Medical Consultancy Co., Ltd. from EPS Medical Consultancy Services Limited for approximately ¥180 million.	CI
22-10-07	GNI Group Ltd. forms joint venture with EPS in Japan focusing on medical device business	CI
22-10-02	MedPeer,Inc. completed the acquisition of Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others.	CI
22-10-02	MedPeer,Inc. announced that it has received ¥306.9 million in funding from EPS Holdings, Inc.	CI
22-08-08	MedPeer,Inc. entered into an agreement to acquire Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others for Ã‘5000 million.	CI
22-08-08	MedPeer,Inc. announced that it expects to receive Ã‘306.9 million in funding from EPS Holdings, Inc.	CI
22-03-30	Suzuken Co., Ltd. completed the acquisition of 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc.	CI
21-12-23	Suzuken Co., Ltd. agreed to acquire 49% stake in EP-PharmaLine Co., Ltd. from EPS Holdings, Inc.	CI
21-09-07	EPS Holdings, Inc.(TSE:4282) dropped from S&P Global BMI Index	CI
21-08-31	Speed Apparel : EPS Creative Setting Up $2 Million Startup Fund	MT
21-07-07	Y&G Limited completed the acquisition of additional 65.7% stake in EPS Holdings, Inc. from Suzuken Co., Ltd., Medical System Network Co., Ltd. and others for ¥ 53.4 billion.	CI

Manager	Title	Age	Since
Fei Liang CEO	Chief Executive Officer	51	-
Daruma Nagaoka PSD	President	-	-
Kenji Sakuma PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Yoshinori Ando BRD	Director/Board Member	69	2011-11-30
Kazuki Sekitani BRD	Director/Board Member	70	2011-03-31
Daruma Nagaoka BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EPS HOLDINGS, INC.	-0.11%	-0.06%	-	-	691M
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.16B
ARGENX SE	-3.11%	-3.53%	+20.19%	+81.44%	57.39B
LONZA GROUP AG	+0.89%	-0.63%	+2.17%	+36.19%	47.64B
REVOLUTION MEDICINES, INC.	+0.36%	+0.81%	+342.39%	+742.40%	44.29B
IQVIA HOLDINGS INC.	-0.96%	-4.50%	+24.96%	+35.38%	42.5B
BEONE MEDICINES AG	-0.20%	-0.77%	+4.13%	+105.50%	40.71B
CELLTRION, INC.	-0.54%	+2.93%	+9.31%	+50.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	-2.68%	+2.92%	+29.33%	+22.72%	28.53B
BIONTECH SE	+0.05%	-1.64%	-8.14%	-11.37%	24.34B
Average	-0.21%	-0.59%	+52.63%	+128.54%	43.39B
Weighted average by Cap.	+0.12%	-0.84%	+56.96%	+138.26%

EPS Holdings, Inc. Stock

Stocks

4282

JP3130770005

Biotechnology & Medical Research

Latest news: EPS Holdings, Inc.

Press Releases: EPS Holdings, Inc.

Quotes and Performance

Managers and Directors: EPS Holdings, Inc.

Other Biotechnology & Medical Research

Company Profile